Tsourdi E, Zillikens MC, Meier C. et al. Fracture risk and management of discontinuation of denosumab therapy: A
systematic review and position statement by ECTS. J Clin Endocrinol Metab 2020; DOI: 10.1210/clinem/dgaa756. Online ahead of print
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.